FTSE 100
8.774,65
PKT
-17,15
PKT
-0,20
%
Werbung
Analysen zu FTSE 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 25.03.24 | Rolls-Royce Buy | Deutsche Bank AG | |
| 25.03.24 | AstraZeneca Sell | UBS AG | |
| 25.03.24 | HSBC Neutral | UBS AG | |
| 25.03.24 | Unilever Sell | UBS AG | |
| 22.03.24 | Rolls-Royce Overweight | Barclays Capital | |
| 21.03.24 | Rolls-Royce Buy | Goldman Sachs Group Inc. | |
| 21.03.24 | Rolls-Royce Buy | UBS AG | |
| 21.03.24 | International Consolidated Airlines Outperform | RBC Capital Markets | |
| 20.03.24 | GSK Buy | Jefferies & Company Inc. | |
| 19.03.24 | Unilever Underperform | Jefferies & Company Inc. | |
| 19.03.24 | easyJet Overweight | JP Morgan Chase & Co. | |
| 19.03.24 | Unilever Underweight | JP Morgan Chase & Co. | |
| 19.03.24 | Unilever Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 19.03.24 | Unilever Sell | UBS AG | |
| 19.03.24 | Unilever Overweight | Barclays Capital | |
| 19.03.24 | Vodafone Group Equal Weight | Barclays Capital | |
| 19.03.24 | Unilever Market-Perform | Bernstein Research | |
| 19.03.24 | Diageo Outperform | Bernstein Research | |
| 19.03.24 | AstraZeneca Sell | UBS AG | |
| 19.03.24 | Unilever Sector Perform | RBC Capital Markets | |
| 19.03.24 | Reckitt Benckiser Buy | UBS AG | |
| 19.03.24 | Reckitt Benckiser Underperform | Jefferies & Company Inc. | |
| 19.03.24 | GSK Buy | UBS AG | |
| 19.03.24 | Rolls-Royce Buy | Jefferies & Company Inc. | |
| 18.03.24 | Reckitt Benckiser Outperform | RBC Capital Markets | |
| 18.03.24 | Shell (ex Royal Dutch Shell) Overweight | Barclays Capital | |
| 18.03.24 | Reckitt Benckiser Buy | UBS AG | |
| 18.03.24 | Reckitt Benckiser Overweight | Barclays Capital | |
| 18.03.24 | Reckitt Benckiser Hold | Deutsche Bank AG | |
| 18.03.24 | Reckitt Benckiser Outperform | Bernstein Research | |
| 18.03.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 18.03.24 | Reckitt Benckiser Underperform | Jefferies & Company Inc. | |
| 18.03.24 | Reckitt Benckiser Neutral | Goldman Sachs Group Inc. | |
| 18.03.24 | BAT Neutral | Goldman Sachs Group Inc. | |
| 15.03.24 | Reckitt Benckiser Outperform | RBC Capital Markets | |
| 15.03.24 | Vodafone Group Buy | UBS AG | |
| 15.03.24 | AstraZeneca Sell | Deutsche Bank AG | |
| 15.03.24 | Glencore Outperform | RBC Capital Markets | |
| 15.03.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 14.03.24 | Shell (ex Royal Dutch Shell) Neutral | UBS AG |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.